# Vera Bradley, Inc.: overview

VRA · Nasdaq · CIK 1495320 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Jan 30

Pages: [Overview](/companies/vra.md) · [Financials](/companies/vra/financials.md) · [Filings](/companies/vra/filings.md) · [Insiders](/companies/vra/insiders.md)

Latest reported revenue: [$71.6m](/filings/0001628280-26-062019.md) for Q2 FY2027, three months to 2026-08-01, from the 10-Q filed Sep 15, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001628280-26-062019).

## Last eight quarters

| Line item | Unit | Q3 FY2025 (2024-11-02) | Q4 FY2025 (2025-02-01) | Q1 FY2026 (2025-05-03) | Q2 FY2026 (2025-08-02) | Q3 FY2026 (2025-11-01) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-05-02) | Q2 FY2027 (2026-08-01) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [70.5](/filings/0001628280-26-021640.md) | [86.4](/filings/0001628280-26-021640.md) | [51.7](/filings/0001628280-26-042444.md) | [70.9](/filings/0001628280-26-062019.md) | [62.3](/filings/0001628280-26-021640.md) | [84.9](/filings/0001628280-26-021640.md) | [55.7](/filings/0001628280-26-042444.md) | [71.6](/filings/0001628280-26-062019.md) |
| Gross margin | % | [54.5%](/filings/0001628280-26-021640.md) | [45.9%](/filings/0001628280-26-021640.md) | [44.1%](/filings/0001628280-26-042444.md) | [50.1%](/filings/0001628280-26-062019.md) | [42.1%](/filings/0001628280-26-021640.md) | [47.8%](/filings/0001628280-26-021640.md) | [51.8%](/filings/0001628280-26-042444.md) | [59.8%](/filings/0001628280-26-062019.md) |
| Operating margin | % | [(11.6%)](/filings/0001628280-25-056518.md) | [(14.4%) d](/filings/0001628280-26-021640.md) | [(34.6%)](/filings/0001628280-26-042444.md) | [(6.5%)](/filings/0001628280-26-062019.md) | [(19.6%)](/filings/0001628280-25-056518.md) | [3.2% d](/filings/0001628280-26-021640.md) | [(8.3%)](/filings/0001628280-26-042444.md) | [5.8%](/filings/0001628280-26-062019.md) |
| Net margin | % | [(18.2%)](/filings/0001628280-26-021640.md) | [(54.4%)](/filings/0001628280-26-021640.md) | [(64.8%)](/filings/0001628280-26-062019.md) | [(6.6%)](/filings/0001628280-26-062019.md) | [(19.9%)](/filings/0001628280-26-021640.md) | [3.1%](/filings/0001628280-26-021640.md) | [(8.7%)](/filings/0001628280-26-062019.md) | [6.3%](/filings/0001628280-26-062019.md) |
| Diluted EPS | $ per share | [(0.46)](/filings/0001628280-26-021640.md) | [(1.69)](/filings/0001628280-26-021640.md) | [(1.20)](/filings/0001628280-26-042444.md) | [(0.17)](/filings/0001628280-26-062019.md) | [(0.44)](/filings/0001628280-26-021640.md) | [0.09](/filings/0001628280-26-021640.md) | [(0.17)](/filings/0001628280-26-042444.md) | [0.15](/filings/0001628280-26-062019.md) |
| Free cash flow | $m | [(25.0) d](/filings/0001628280-25-056518.md) | [17.3 d](/filings/0001628280-26-021640.md) | [(19.8)](/filings/0001628280-26-042444.md) | [(6.1) d](/filings/0001628280-26-062019.md) | [(4.5) d](/filings/0001628280-25-056518.md) | [17.1 d](/filings/0001628280-26-021640.md) | [(5.6)](/filings/0001628280-26-042444.md) | [22.3 d](/filings/0001628280-26-062019.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2022 (2022-01-29) | FY2023 (2023-01-28) | FY2024 (2024-02-03) | FY2025 (2025-02-01) | FY2026 (2026-01-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [540](/filings/0001495320-24-000026.md) | [500](/filings/0001495320-25-000019.md) | [384](/filings/0001628280-26-021640.md) | [319](/filings/0001628280-26-021640.md) | [270](/filings/0001628280-26-021640.md) |
| Gross margin | % | [53.3%](/filings/0001495320-24-000026.md) | [47.8%](/filings/0001495320-25-000019.md) | [53.2%](/filings/0001628280-26-021640.md) | [49.8%](/filings/0001628280-26-021640.md) | [46.4%](/filings/0001628280-26-021640.md) |
| Operating margin | % | [5.0%](/filings/0001495320-24-000026.md) | [(19.0%)](/filings/0001495320-25-000019.md) | [3.0%](/filings/0001628280-26-021640.md) | [(9.0%)](/filings/0001628280-26-021640.md) | [(11.8%)](/filings/0001628280-26-021640.md) |
| Net margin | % | [3.3%](/filings/0001495320-24-000026.md) | [(11.9%)](/filings/0001495320-25-000019.md) | [2.0%](/filings/0001628280-26-021640.md) | [(19.5%)](/filings/0001628280-26-021640.md) | [(17.7%)](/filings/0001628280-26-021640.md) |
| Diluted EPS | $ per share | [0.52](/filings/0001495320-24-000026.md) | [(1.90)](/filings/0001495320-25-000019.md) | [0.25](/filings/0001628280-26-021640.md) | [(2.15)](/filings/0001628280-26-021640.md) | [(1.71)](/filings/0001628280-26-021640.md) |
| Free cash flow | $m | [34.4](/filings/0001495320-24-000026.md) | [(21.7)](/filings/0001495320-25-000019.md) | [44.2](/filings/0001628280-26-021640.md) | [(24.5)](/filings/0001628280-26-021640.md) | [(13.3)](/filings/0001628280-26-021640.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/vra/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $5.0m | 1,289,059 |  | Added +692,067 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $4.0m | 1,031,861 |  | Reduced −6,946 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $3.3m | 853,863 |  | Reduced −160,180 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $3.2m | 810,955 |  | Reduced −130,051 |
| [Peapod Lane Capital LLC](/funds/2050979.md) | 2026-06-30 | $2.7m | 684,766 |  | Reduced −149,341 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $2.3m | 579,041 |  | Added +72,668 |
| [MARSHALL WACE, LLP](/funds/1318757.md) | 2026-06-30 | $2.0m | 501,404 |  | Reduced −305,562 |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.7m | 433,299 |  | Added +23,981 |
| [TWO SIGMA INVESTMENTS, LP](/funds/1179392.md) | 2026-06-30 | $1.5m | 385,359 |  | Added +78,582 |
| [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $1.3m | 322,927 |  | Reduced −84,876 |

## Recent filings

[All 1,384 filings](/companies/vra/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-09-15 | 18:59 ET | [10-Q](/filings/0001628280-26-062019.md) | Quarterly report, period 2026-08-01 | 0001628280-26-062019 |
| 2026-09-15 | 12:13 ET | [8-K](/filings/0001628280-26-061971.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-061971 |
| 2026-07-24 | 20:08 ET | [8-K](/filings/0001628280-26-049595.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001628280-26-049595 |
| 2026-06-11 | 17:39 ET | [10-Q](/filings/0001628280-26-042444.md) | Quarterly report, period 2026-05-02 | 0001628280-26-042444 |
| 2026-06-11 | 12:01 ET | [8-K](/filings/0001628280-26-042374.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-042374 |
| 2026-06-09 | 13:09 ET | [8-K](/filings/0001628280-26-041779.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-041779 |
| 2026-04-24 | 17:22 ET | [DEF 14A](/filings/0001193125-26-176477.md) | Proxy statement, period 2026-06-04 | 0001193125-26-176477 |
| 2026-04-24 | 12:00 ET | [8-K](/filings/0001628280-26-027024.md) | 5.02 Departure or appointment of officers or directors | 0001628280-26-027024 |
| 2026-04-17 | 21:02 ET | [8-K](/filings/0001628280-26-025831.md) | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-025831 |
| 2026-03-27 | 17:38 ET | [10-K](/filings/0001628280-26-021640.md) | Annual report, period 2026-01-31 | 0001628280-26-021640 |

## Latest annual report

[Form 10-K for the fiscal year ended Jan 31, 2026](/filings/0001628280-26-021640.md), filed Mar 27, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1495320
- Tickers: VRA
- Exchange: Nasdaq
- SIC code: 3100 Leather & Leather Products
- State of incorporation: not reported
- Filer category: Non-accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.